| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | WO2002083868A3 Peroxide-driven cytochrome p450 oxygenase variants |
| 08/05/2004 | US20040153254 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 08/05/2004 | US20040152875 Novel purinergic receptor |
| 08/05/2004 | US20040152869 Comprises amino acid sequences which serve as substrates for a disintegrin and metalloprotease (ADAM) for use in identification of modulator for treatment of asthma |
| 08/05/2004 | US20040152660 Autoinducer synthase modulating compounds and uses therefore |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152657 Immunomodulatory oligonucleotides |
| 08/05/2004 | US20040152656 For use antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics |
| 08/05/2004 | US20040152655 Antisense oligonucleotides that inhibit expression of HIF-1 |
| 08/05/2004 | US20040152648 Use of a pyruvate-kinase or a nucleic acid encoding a pyruvate-kinase as a target for the modulation of apoptosis |
| 08/05/2004 | US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152187 System, apparatus and method for inferring glucose levels within the peritoneum with implantable sensors |
| 08/05/2004 | US20040152172 Generating pool of RNA interfering sequences via transformation, expression and recovery of cloned vector sequences associated with full hairpin random oligonucleotides; gene expression inhibition |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152151 wastewater treatment; biocatalysts; pollution control |
| 08/05/2004 | US20040152150 Detecting airborne microorganisms |
| 08/05/2004 | US20040152148 Novel methods involving the determination of activity of enzymes that use or produce prostaglandin endoperoxide H2 |
| 08/05/2004 | US20040152147 Silica coated nanoparticle bead for use in bioassay which binds labelled arginine to citrulline and identifies nitric oxide synthase (NO) modulators for treating shock, inflammation, stroke, diabetes, hypertension, asthma and urogenital disorders |
| 08/05/2004 | US20040152146 Methods for screening compounds for use in the treatment of disease |
| 08/05/2004 | US20040152145 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof |
| 08/05/2004 | US20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152142 Using immobilized antibodies to identify preferential particles in solution; immunological and diagnostic assay |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152131 Methods for end point temperature testing |
| 08/05/2004 | US20040152126 Expression vector comprising cyclooxygenase promoter and reporter gene for use in identifying transcription modulators of cyclooxygenase activity; enzyme inhibitors |
| 08/05/2004 | US20040152124 Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| 08/05/2004 | US20040152123 for drug screening enzyme inhibitors for cancer treatments; biochips; genetic engineering |
| 08/05/2004 | US20040152122 simple in the design and easy to miniaturize and integrate into complex apparatuses; uses non-thermostable polymerases; temperature distribution that induces circulation so that the denaturation, annealing, and polymerization occur sequentially |
| 08/05/2004 | US20040152121 for diagnosis of cardiomyopathy in asymptomatic patients; genetic engineering; kits |
| 08/05/2004 | US20040152119 Terminal phosphate labeled nucleotide; quantitative analysis using polymerase |
| 08/05/2004 | US20040152118 Methods and compositions for detecting nucleic acid sequences |
| 08/05/2004 | US20040152117 involve the use of double stranded RNA expression libraries; selectively regulates expression of genes in vertebrate cells without the associated toxicity of interferon response |
| 08/05/2004 | US20040152116 G-quadruplex binding assays and compounds therefor |
| 08/05/2004 | US20040152112 Compositions and methods for cancer diagnosis and therapy |
| 08/05/2004 | US20040152111 Compositions and methods for diagnosing and treating mood disorders |
| 08/05/2004 | US20040152110 Use of semaphorin 3A for diagnosing and treating cancer, especially prostate cancer |
| 08/05/2004 | US20040152109 Methods and compositions for determining risk of treatment toxicity |
| 08/05/2004 | US20040152108 comprises a computer program product for comparing subsequences derived from a primary subunit sequence and from at least one secondary subunit sequence to facilitate inference of the primary subunit sequence; genetic engineering |
| 08/05/2004 | US20040152107 Gene signature of electroshock therapy and methods of use |
| 08/05/2004 | US20040152106 for drug screening treatments for huntington's disease/alzheimer's/parkinson's disease, schizophrenia, depression, anxiety, stress, trauma, stroke |
| 08/05/2004 | US20040152104 Nucleic acid amplification |
| 08/05/2004 | US20040152103 by co-expressing polypeptides using escherichia coli; immunoglobulins; single chain FV fragments; genetic engineering |
| 08/05/2004 | US20040152100 for identification of desired microorganisms by the streptavidin-fluorescein detection of the biotin-labeled probe; solid phase synthesis |
| 08/05/2004 | US20040152097 using solid phase synthesis for quantitative analysis with high sensitivity and enhanced throughput; genetic engineering |
| 08/05/2004 | US20040152091 Electricity detector circuits; one nucleic acid acts as scavenger; other labeled with redox system |
| 08/05/2004 | US20040152090 Method for the amplificaton and detection of dna using a transcription based amplification |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152087 Identification |
| 08/05/2004 | US20040152086 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydragenase gene associated with altered lignification in loblolly pine |
| 08/05/2004 | US20040152085 Surface for collection and/or purification of nucleic acids |
| 08/05/2004 | US20040152082 Biopolymer array reading |
| 08/05/2004 | US20040152080 Pretreatment Dna; amplification using polymerase primers; incubation in solution of hydrogen sulfite; polymerase chain reactions; brain disorders; skin disorders; bone disorders; antiinflammatory agents; headaches; sexual disorders |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040152077 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 08/05/2004 | US20040152075 Genetic marker test for lupus |
| 08/05/2004 | US20040152073 Human cellular protein gastrointestinal glutathione peroxidase active materials |
| 08/05/2004 | US20040152072 Reverse transcription |
| 08/05/2004 | US20040152067 Impedance based apparatuses and methods for analyzing cells and particles |
| 08/05/2004 | US20040151736 Use of cross-protection to identify novel vaccine candidates for infectious agents |
| 08/05/2004 | US20040151724 Antibody fab fragments specific for breast cancer |
| 08/05/2004 | US20040149577 Rapid, accurate, sensitive cholesterol determination in aqueous solution; reuse, shelf life, negligible leaching |
| 08/05/2004 | DE19806962B4 Markierung von Nukleinsäuren mit speziellen Probengemischen Labeling of nucleic acids with specific biological samples |
| 08/05/2004 | DE10302370A1 Assays zur Suche von Hemmstoffen der IspH-Reaktion Assays for the search of inhibitors of IspH reaction |
| 08/05/2004 | DE10301592A1 Verwendung von an GSTM bindenden Substanzen zur Diagnose und Behandlung des Harnblasenkarzinoms Use of binding substances to GSTM for the diagnosis and treatment of bladder cancer |
| 08/05/2004 | DE10064689B4 Verfahren zur Bestimmung der Blutzellhämostase Method for determining the Blutzellhämostase |
| 08/05/2004 | CA2829477A1 Gene expression markers for breast cancer prognosis |
| 08/05/2004 | CA2829476A1 Gene expression markers for breast cancer prognosis |
| 08/05/2004 | CA2829472A1 Gene expression markers for breast cancer prognosis |
| 08/05/2004 | CA2802143A1 Cancer therapy sensitizer |
| 08/05/2004 | CA2513730A1 Method for comprehensive identification of cell lineage specific genes |
| 08/05/2004 | CA2513675A1 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 08/05/2004 | CA2513642A1 Diagnosis and prognosis of breast cancer patients |
| 08/05/2004 | CA2513626A1 Nucleic acid amplification using non-standard bases |
| 08/05/2004 | CA2513575A1 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | CA2513572A1 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | CA2513470A1 Modulation of deubiquitinase family members |
| 08/05/2004 | CA2513302A1 Haplotype analysis |
| 08/05/2004 | CA2513292A1 Circulating mrna as diagnostic markers for pregnancy-related disorders |
| 08/05/2004 | CA2513184A1 Substrate detection assay |
| 08/05/2004 | CA2513182A1 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | CA2513125A1 Probe conjugation to increase multiplex binding motif preference |
| 08/05/2004 | CA2513117A1 Gene expression markers for breast cancer prognosis |
| 08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | CA2512549A1 Methods for diagnosing osteoporosis or a susceptibility to osteoporosis based on haplotype association |
| 08/05/2004 | CA2512239A1 Human osteoporosis gene |
| 08/05/2004 | CA2511570A1 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | CA2511252A1 Production of at least one emulsifier in a foodstuff using a lipid acyltransferase enzyme |
| 08/05/2004 | CA2488677A1 Method of inhibiting prostate cancer cell proliferation |
| 08/04/2004 | EP1443328A2 Cobalamin assay |
| 08/04/2004 | EP1443118A1 Primers for detecting Fusobacterium nucleatum by PCR methods and methods for detection |